Rosuvastatin is one of the most widely prescribed statins, and most people tolerate it well for years. But long-term use does carry a small set of real side effects worth understanding, particularly involving muscles, blood sugar, and liver enzymes. Here’s what the evidence actually shows about each one.
Muscle Pain and Weakness
Muscle symptoms are the most commonly reported long-term side effect of rosuvastatin. These range from mild soreness or stiffness to more noticeable weakness that can interfere with daily activities. Over five years of statin treatment, roughly 50 to 100 people out of every 10,000 treated will develop symptomatic muscle pain or weakness they wouldn’t have otherwise experienced.
The more serious concern is a condition called myopathy, where muscle fibers break down significantly. This happens to about 1 in 10,000 people per year on a statin. The most severe form, rhabdomyolysis, involves rapid muscle breakdown that can damage the kidneys. It’s genuinely rare, occurring in about 2 to 3 people per 100,000 treated per year. For context, that means if 100,000 people took rosuvastatin for a full year, two or three would develop rhabdomyolysis.
If you experience persistent muscle pain, tenderness, or dark-colored urine while taking rosuvastatin, those symptoms deserve prompt attention. Most muscle discomfort from statins is mild and manageable, but the severe end of the spectrum needs to be caught early.
Increased Diabetes Risk
Long-term rosuvastatin use raises the likelihood of developing type 2 diabetes, and the risk scales with dose. A large analysis published in The Lancet Diabetes & Endocrinology found that low-to-moderate intensity statin therapy increased new diabetes diagnoses by about 10%, while high-intensity therapy (which includes the higher doses of rosuvastatin) increased them by 36%.
That sounds alarming as a percentage, but the absolute numbers matter. Among people without diabetes at baseline, average blood sugar levels (measured by HbA1c) rose by only 0.06% to 0.08% compared to placebo. That’s a tiny shift for any individual. What it means in practice is that statins tend to nudge people who are already borderline toward a diabetes diagnosis slightly sooner than they might have arrived there on their own. If your blood sugar is already in a healthy range, the risk of rosuvastatin tipping you into diabetes is small. If you’re already prediabetic, it’s worth monitoring your blood sugar more closely.
Liver Enzyme Changes
Rosuvastatin can cause elevations in liver enzymes, which sometimes raises concern about liver damage. In clinical trials reviewed by the FDA, persistent elevations (more than three times the upper limit of normal) occurred in 0% to 0.4% of patients at the commonly prescribed 10 mg and 20 mg doses. At the highest dose tested (80 mg, which is above the approved maximum), the rate was 1.1%. No cases of liver failure or unexplained hepatitis were observed in these trials.
This is reassuring enough that the FDA stopped recommending routine liver enzyme monitoring for statin patients back in 2012. The current guidance from the American Heart Association is straightforward: get a baseline liver test before starting the medication, but don’t bother with repeat testing unless you develop symptoms like yellowing skin, unusual fatigue, itching, nausea, or abdominal pain.
Cognitive Effects
Reports of “brain fog,” memory lapses, and confusion while on statins have generated a lot of concern and a fair amount of research. The FDA added a warning about possible cognitive effects to statin labels in 2012. But the actual evidence for long-term cognitive harm is weak.
A study of more than 18,000 adults aged 65 and older, published in the Journal of the American College of Cardiology, tracked participants for nearly five years. Statin users were no more likely to develop dementia than non-users. There were also no differences in memory, language, executive function, or processing speed. Other studies have produced mixed results, leading researchers to describe the overall picture as “inconsistent.” If statins do affect cognition, the effect is likely subtle and not permanent.
Rosuvastatin is actually one of the statins least expected to cause cognitive symptoms. It’s a “hydrophilic” statin, meaning it doesn’t cross into the brain as easily as fat-soluble statins like atorvastatin or simvastatin. If you notice brain fog or concentration problems, switching to rosuvastatin (if you’re not already on it) or adjusting the dose are common strategies.
Cataract Risk
There is some evidence linking long-term statin use to a modestly increased risk of cataracts. Danish researchers used a genetic approach to simulate the effect of lifelong statin therapy and found that the degree of cholesterol lowering associated with how statins work was tied to a 14% higher odds of cataract development and a 25% higher odds of needing cataract surgery. Importantly, the researchers noted this genetic model mimics decades of exposure, similar to what someone with a genetic cholesterol condition would experience from birth. It may not apply the same way to someone who starts rosuvastatin at age 55.
This remains an area where the data is suggestive rather than definitive, and the absolute increase in risk, if real, appears modest.
What Monitoring Looks Like Long-Term
If you’ve been on rosuvastatin for years, the good news is that extensive routine testing isn’t necessary. Current guidelines say you don’t need regular liver enzyme checks unless symptoms develop. You also don’t need routine creatine kinase (CK) testing for muscle health. Most people with muscle discomfort from statins have normal CK levels anyway, and elevated CK can show up after a hard workout in perfectly healthy people. CK testing is reserved for people with severe muscle symptoms.
What does make sense is periodic blood sugar screening, especially if you have risk factors for diabetes like excess weight, a family history, or prediabetes. Your cholesterol levels themselves should be checked periodically to confirm the medication is doing its job.
CoQ10 for Muscle Symptoms
Coenzyme Q10 (CoQ10) supplements are frequently recommended alongside statins to help with muscle symptoms. Statins reduce your body’s production of CoQ10, and the theory is that replenishing it might ease muscle pain. A meta-analysis of 12 randomized controlled trials involving 575 patients found that CoQ10 supplementation did improve statin-related muscle pain, weakness, cramping, and tiredness compared to placebo. However, it didn’t actually change CK levels, suggesting the benefit may be more about how muscles feel than about preventing measurable muscle damage.
CoQ10 isn’t guaranteed to help everyone, but it’s low-risk and inexpensive. Typical doses used in the studies ranged from 100 to 200 mg daily. If muscle discomfort is your main concern with long-term rosuvastatin use, it’s a reasonable thing to try before considering a dose change or switching medications.